M. М. Tanashyan

1 ta ish

Scientific Center of Neurology, Moscow, Russia

1. Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)

   Fedin Ai, В. В. Захаров, M. М. Tanashyan +4

   MaqolaNeurological Disorders and TreatmentsS S Korsakov Journal of Neurology and Psychiatry20212 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.000049